Skip to main content

Table 4 Comparison time-course serum profiles short PFS vs. long PFS

From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

m/z

p-value

peptide ID

3215.1939

0.0021001

 

1616.6366

0.010132

P-FPA

1292.4157

0.013272

 

1418.539

0.013272

 

1596.189

0.022018

 

1440.5407

0.043474

 

1670.5947

0.044759

 
  1. Seven peaks were significantly differential comparing NSCLC patients with short progression-free survival and long progression-free survival, using three time points: pre-treatment, after two cycles of treatment and end of treatment. Ordered by p-value.
  2. Abbreviation: P-FPA: phospho-fibrinopeptide A.
Back to article page

Proteome Science

ISSN: 1477-5956